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The human  receptor  for C3b  and  C4b  (CR1)  was  initially  isolated  from pooled 
donor erythrocyte membranes and characterized as an integral membrane glycopro- 
tein  of ~205,000  dahons  on  SDS-polyacrylamide  gels  (1-3).  Polyelonal  antibodies 
against  this  glycoprotein  immunoprecipitated  a  similar  molecule  from other  CR1- 
bearing cells such as polymorphonuclear cells  (PMN),  macrophages, and B lympho- 
cytes (1).  Recently, we have demonstrated  that  CR1  is polymorphic in erythrocytes 
(E)  obtained  from  normal  donors  (4).  Autoradiographs  of purified  surface-labeled 
receptor demonstrated that ~70% of individuals had a  single major band at  190,000 
daltons, ~3% of individuals had a  major band at 220,000 dahons and the remaining 
individuals  had  both  major  bands  at  190,000  and  220,000  dahons.  Family studies 
provided evidence for transmission  of the  190,000- and  220,000-dalton  major bands 
of CR1  by two codominant  alleles.  We have now extended  these  investigations  by 
analyzing the structure  of this receptor on human leukocytes. These studies demon- 
strate  that  although  leukocytes from individual  donors express  CR1  polymorphism 
similar  to that  on  E,  specific structural  differences  in  CR1  exist  among peripheral 
blood cells. 
Materials  and Methods 
Purification of Human E, Polymorphonuclear, and Mononuclear Cells. E were obtained from 30 ml of 
whole blood collected in 500 U sodium heparin (Abbott Laboratories, North Chicago, IL). The 
bully coat was removed after centrifugation (800 g for 8 min) and the pellet was then washed 
three times with 0.01 M potassium phosphate, 0.15 M  NaCI, pH 7.4 (PBS)  to obtain ~5 ml of 
packed E from each donor (4). Leukoeytes were obtained at the same time as E from 250 ml of 
whole blood collected in 50 ml of 6% dextran (Sigma Chemical Co., St.  Louis, MO), 0.15  M 
NaCI and 2,500  U  of heparin.  Polymorphonuclear (PMN)  and mononuclear cells were then 
separated by Ficoll-Hypaque method (5). The pellets contained >98% PMN and >90% were 
viable by trypan blue exclusion. The mononuclear layer contained monocytes and lymphocytes 
(variable  ratio  from each  donor)  that  were  >90%  viable and  <2%  PMN.  In some donors 
mononuclear cells were further separated into monocyte-enriched or B lymphocyte-enriched 
populations by Dr. R. MacDermott, Washington University, as previously reported (6). 
Surface Labeling, Solubilization, and Isolation ofCR1.  E (~5 ×  10  ~ cells),  PMN, or mononuclear 
cells  (~2 ×  10  s cells) were suspended in 4 ml PBS and iodinated with 0.25  mCi of 125I (New 
England Nuclear, Boston, MA) by a modified lactoperoxidase method (4). Following iodination, 
E  were  lysed  at  4°C  with  15  ml  of distilled  H20  containing  protease  inhibitors  (2  mM 
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phenylmethylsulfonyl  fluoride, 3 mM EDTA, 1 #M pepstatin,  and 20 mM iodoacetamide)  for 
1 min and then 15 ml of 0.3 M NaCI with the same inhibitors was added.  E stroma were then 
collected  by centrifugation  at  33,000 g for 20 min.  E stroma (5  X  109 cell equivalents)  and 
intact PMN and mononuclear cells (1 ×  10  s ceils) were then solubilized at 4°C in 1 ml PBS, 1% 
Nonidet P-40 (NP-40) in the presence of the same protease inhibitors  used for lysis of E. After 
centrifugation at 33,000 g for 20 min, supernatants from each cell preparation were stored at 
-22°(2. To purify CR1, solubilized labeled preparations  were thawed and immunoprecipitated 
as previously reported  (4) with monoclonal mouse IgG1 antibody prepared against  C:R1 (7). 
Briefly, preparations were incubated with excess anti-CIR1 and the antibody was then bound 
to  purified  membranes  from  Staphylococcus aureus, Cowan  I  strain  (SAC/). After  extensive 
washings, proteins  bound to the pellet were removed by heating the pellet in electrophoresis 
buffer (0.25 M Tris-HC1, pH 6.8, 2% SDS, 10% glycerin, and 0.001% bromophenol blue) and 
the buffer was then loaded directly on gels. In some donors, CR1 was also isolated by affinity 
chromatography with C3-sepharose (4). 
SDS-Polyacrylamide Gel Electrophoresis. Slab gel electrophoresis was performed according to the 
method of Laemmli (8). Reduction and alkylation of samples, molecular weight standards,  and 
autoradiographic techniques  were previously described  (4). A Zeineh  scanning densitometer 
(Biomed Instruments Inc., Fullerton,  CA) was used to quantitate band intensity  (4). 
Results 
Autoradiographs of immunoprecipitates  of a2zI surface-labeled  peripheral  blood 
ceils from three selected donors are shown in Figs.  1 and 2.  In donor D1  (a known 
heterozygous individual), two major radiolabeled bands were seen on autoradiographs 
in all three types of peripheral blood cells  (Fig.  1, tracks 1-3). In E, two predominant 
(major) bands were found at Mr of 190,000  and 220,000 (track 1, solid arrows to left). 
Less intense (minor) bands were noted -15,000 daltons above each major band (open 
arrows  to  left  of track  1).  Densitometric scanning of the  autoradiographs disclosed 
that <10% of radioactivity in the receptor was found in these minor bands. In PMN 
from the same donor, bands did not align with major or minor bands in E but were 
-5,000 daltons greater (Mr of 195,000 and 225,000; compare track 2 with track 1). In 
contrast to PMN, bands derived from mononuclear cells aligned with major bands in 
E (track 3). The less intense minor bands that were demonstrated in E were not found 
in  either  PMN  or  mononuclear cells,  even  with  prolonged exposure  of autoradi- 
ographs. 
The same radiolabeled solubilized preparations  from E,  PMN, and mononuclear 
cells  of donor D1  were also immunoprecipitated with  a  control mouse monoclonal 
antibody with no known specificity (Fig.  1, tracks 4-6, respectively). This monoclonal 
had the same subclass  (IgG1) and was used at the same concentration as anti-CR1. 
Radiolabeled  bands corresponding to the  receptor bands were  not  precipitated  by 
nonspecific monoclonal antibody. With either the nonspecific or specific monoclonal 
antibody,  bands  were  occasionally  noted  at  ~94,000  daltons,  particularly  in  E 
preparations (tracks 1 and 4). As reported previously, this 94,000-dahon band is not 
found  on  autoradiographs  of CRI  isolated  by affinity  chromatography with  C3- 
Sepharose (4). 
Experiments  similar  to  those shown in  Fig.  1 were  performed with  two selected 
homozygous donors, D2 and D3 (Fig.  2). In donor D2, a single major band was found 
at  190,000  daltons on E  (track 2, solid arrow)  that aligned with the lower major band 
in donor D1 (track 1). In donor D3, a single major band was found at 220,000 daltons 
on E  (track 3, solid arrow) that aligned with the upper major band in donor D1 (track 
1). Less intense minor bands were noted at  -15,000 daltons greater than the major 
bands in donors D2 and D3 (open arrows).  Densitometric scanning of autoradiographs 2162  DYKMAN ET AL.  BRIEF DEFINITIVE REPORT 
Fic.  1.  Purified peripheral blood cells  were labeled with 125I, solubilized, and immunoprecipitated 
with monoclonal anti-CR1 (tracks 1-3) or control antibody with no known specificity  (tracks 4-6). 
Autoradiographs of all samples run on the same nonreduced 5% gel are shown for erythrocytes 
(RBC) in tracks 1 and 4, for PMN in tracks 2 and 5, and for mononuclear cells (MONO) in tracks 
3 and 6. 
in  these  donors  demonstrated  that  ~12%  of the  radioactivity  in  the  receptor  was 
found in minor bands in both donors. 
Autoradiographs of immunoprecipitations of solubilized labeled PMN and mono- 
nuclear cells in homozygous donors D2 and D3 gave single band patterns  (tracks 4- 
7). In both donors, bands immunoprecipitated from PMN did not align with major or 
minor bands in E and were ~5,000 dahons greater than the radiolabeled major band 
found on their respective E  (compare track 4 with track 2, and track 5 with track 3). 
In mononuclear cells, single bands in both donors (tracks 6 and 7) aligned with major 
bands in their respective E  (tracks 2 and 3) and were lower than those in PMN (tracks 
4 and 5). As in donor D1 in Fig.  1, minor bands were not apparent in leukocytes from 
donors D2 or D3. 
Differences between CR 1 on PMN and E  or mononuclear cells were also apparent 
on reduced and alkylated gels. In addition, patterns found with gradient gels (6-18%) 
were similar to  those on  5% nongradient  gels.  When  CR1  was purified  by affinity 
chromatography with C3-Sepharose, autoradiography demonstrated similar patterns 
among these and other donors.  Minor  bands on E  and differences in CR1  between 
PMN and E  or mononuclear cells were found whether preparations were isolated by 
affinity chromatography or immunopreeipitation. 
In  some  donors  CR1  was  immunopreeipitated  from  monocyte-enriched  (-81% 
monocytes,  19%  B  lymphoeytes)  or  B  lymphocyte-enriched  populations  (-90%  B 
lymphocytes, 8% null,  and  2% T  ceils).  Both monocyte and B  lymphocyte-enriched 
populations had similar Mr receptors on autoradiographs  as found in nonseparated 
mononuclear  preparations.  In cells obtained  from human  eosinophil  cultures  from 
normal  donors  (>98%  eosinophils,  gift  of Drs.  Salomon  Asmar  and  Jeff Herzig, 
Washington  University)  immunoprecipitation  of CR1  demonstrated  a  Mr  receptor 
similar to that found on PMN. 
Mixing  experiments  were  performed  to  determine  whether  alterations  in  CR1 
occurred  during  solubilization  and  purification.  In  these  experiments,  labeled ceils 
were mixed after surface labeling with equal numbers of unlabeled cells of a different 
type. Combined preparations were then solubilized and CR1  purified  by immuno- DYKMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT  2163 
FIc.  2.  Peripheral blood cells from three selected donors (D1, D2, and D3) were surface labeled, 
immunoprecipitated  by  anti-CR1,  and  analyzed  as  in  Fig.  1.  Autoradiographs  of a  single 5% 
nonreduced gel are shown for erythroeytes (RBC) in tracks 1-3, for PMN in tracks 4 and 5, and for 
mononuclear cells (MONO) in tracks 6 and 7. 
precipitation. When labeled PMN were mixed with unlabeled mononuclear cells, the 
Mr  of PMN  remained  unchanged.  This  demonstrated  that  lower Mr  receptors  in 
mononuclear cells could not be explained by proteolytic enzymes in mononuclear cells 
degrading initially high Mr receptors similar to those in PMN. When labeled E were 
mixed with unlabeled mononuclear or polymorphonuclear cells, the minor band Mr 
remained  unchanged  and  the  proportion  of minor  band  in  E  in  a  given  donor 
remained constant. This suggests that the absence of minor bands on leukocytes could 
not  be explained by degradation.  Finally,  to determine whether  increases  in  PMN 
CR 1 were due to modification of a  lower Mr receptor, labeled mononuclear cells or 
erythrocytes  were  mixed  with  unlabeled  PMN.  The  Mr  of  the  mononuclear  or 
erythrocyte CR1 remained unchanged. 
Peripheral  blood  cells  (E,  PMN,  and  mononuclear  cells)  from  four  additional 
unrelated  heterozygous donors were surface-labeled and  CR1  was  then  isolated  by 
immunoprecipitation  or  by affinity chromatography  (Table  I).  On  E,  the  ratio  of 
radioactivity in the 220,000  to  190,000 molecules varied considerably among donors 
(from 0.09 to 3.10);  however, repeat examinations in individual  donors gave similar 
ratios  (within  0.10).  When  the ratio of radioactivity in  the upper to lower band  in 
PMN or mononuclear cells was measured by densitometry for each of these donors, 
consistently greater radioactivity was found in the upper band in leukocytes than in 
the upper major band in E. Differences in ratios among cell types in donor D1 can be 
appreciated by review of Fig.  1 (compare tracks 2 and 3 with track 1). Donor D4 had 
the most marked shift with  a  ratio of 0.1  on E, but > 1.0 on PMN or mononuclear 
cells.  Of interest  is that  this  individual's sister also has a  ratio of 0.1  on her E  and 
among other related heterozygous siblings similar ratios have also been found. These 
findings suggest this ratio on E  may be genetically determined. 
Discussion 
In a previous study we demonstrated polymorphism ofE CR 1 in normal individuals 
(4). In the present report, this polymorphism was shown to extend to other peripheral 
blood  cells  that  possess  this  integral  membrane  glycoprotein.  A  phenotype  was 
expressed on  PMN,  eosinophils, and  mononuclear cells  (B  lymphoeytes and  mono- 
cytes)  that  was similar to that  on E.  Donors with  a  single major band  on E  had  a 
single band on  leukocytes;  donors with  both  major bands on  E  had  two  bands  on 
leukocytes. Since a similar phenotype was expressed on all peripheral blood leukocytes 
in the same donor, differences in posttranscriptional  modification of CR 1 molecules 2164  DYKMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE I 
Ratio of Upper to Lower Receptor Band in Erythrocytes and Leukocytes of 
Unrelated Heterozygous Donors 
Donor  E*  PMN*  MONO* 
D1  0.4  1.7  1.5 
D4  0.1  1.5  1,2 
D5  0.4  1.2  0.8 
D6  0.7  1.6  1,7 
D7  3.1  ND  5,6 
* Ratio of radioactivity found in 220,000-dalton  divided by 190,000-dalton  band. Values 
were determined by densitometric scanning as described in Materials and Methods for 
E and mononuclear cells (MONO). 
* Similar ratio of 225,000-dalton  divided by 195,000-dalton  band in PMN. 
ND, not done. 
could  account  for  the  small  Mr  differences  observed  in  leukocytes  (~5,000-dalton 
increase in PMN or eosinophils). Further structural studies are needed to determine 
whether  carbohydrate  or peptide  differences  account  for Mr  increases  in  PMN  or 
eosinophil CR1.  Since CR1 on PMN has been shown to mediate absorptive endocy- 
tosis  (9),  it  will  be of considerable  interest  to  determine  whether  the  5,000-dalton 
difference is related to this function. 
Two other  differences were  noted  between  CR1  structure  on  E  compared with 
PMN or mononuclear cells. First, minor bands were not  found on leukocytes. In E, 
although minor bands are variable from individual to individual  (none to 25% of the 
radioactivity  incorporated  into  the  receptor)  they  are  reproducible  in  the  same 
individual  (4).  One  possibility  is  that  they  represent  an  acquired  change  in  CR1 
structure during the 120-d lifetime of E. However, employing differential centrifuga- 
tion to separate young and old E  (10-fold enhancement of reticulocytes in young cell 
population), no differences in minor band intensity were found on young vs. old E 
(unpublished data). This suggests that minor bands are not acquired but are constant 
once the E has entered the circulation. We favor the possibility that these minor bands 
represent  incompletely processed  precursor  molecules that  bind  specifically to  C3- 
Sepharose (4). 
Another observation of interest is the variable autoradiographic  intensity of poly- 
morphic CR1 receptors among different cell types in unrelated heterozygous individ- 
uals  (donors D1  and D4 through D7  in Table I). As noted previously, heterozygous 
individuals  express variable ratios of the  220,000  and  190,000  bands on  E  but  the 
ratio is characteristic  for each individual  (4).  In the present  study, when CR1  was 
examined on leukocytes of heterozygous donors,  220,000  (mononuclear)- or 225,000 
(PMN)-dalton bands were more intense on autoradiographs than on E. Differences in 
band intensity on E  among individuals  and between E  and leukocytes in the same 
individuals could be accounted for by variable surface-labeling or turnover of receptor 
molecules. Neither of these possibilities seems likely, however, since there would have 
to be large differences (up to 30-fold) in labeling efficiency or turnover of similar Mr 
receptor molecules on E  among individuals or on E compared with leukocytes in the 
same individuals. We feel our data are most compatible with unequal  expression of 
the  two  receptor  molecules  among  heterozygous  individuals.  Other  examples  of 
unequal expression in heterozygous individuals have been reported among peripheral 
blood ceils. In individuals who are heterozygous for peptidase A (two alleles at a single 
locus), different quantities of each allelic product are found on leukocytes than on E DYKMAN ET AL.  BRIEF DEFINITIVE REPORT  2165 
(10).  This  mechanism  would  provide  an  explanation  not  only  for  the  differences 
among cell types but also for differences on E among heterozygous donors. 
Although a number of other membrane receptors have been characterized, examples 
of structural  heterogeneity  among donors  and  cell  types such  as that  reported  for 
CR1  in this study have not been noted.  If there are functional  differences between 
these receptor molecules, expression of different CR 1 molecules on certain cells could 
have  important  biologic  consequences.  Further  characterization  of  the  structural 
differences  in  the  human  CR1  receptor  among  cell  types  and  individuals  are  in 
progress. 
Summary 
In these studies CR1  polymorphism previously demonstrated on erythrocytes (E) 
was also found on ORl-bearing peripheral blood leukocytes including polymorpho- 
nuclear  (PMN),  eosinophils,  monocytes, and  B  lymphocytes. However several cell- 
specific differences in  CR1  were  found:  (a)  an  ~5,000-dalton  increase  in  CR1  on 
PMN and eosinophils, (b) unequal band intensity among heterozygotes suggests that 
there is preferential expression of 220,000- or 225,000-dalton  receptors on leukocytes 
compared  to  E,  and  (c)  "minor"  bands,  ~15,000  daltons  larger  than  the  major 
receptor  molecule,  were  found  on  E  but  not  on  leukocytes.  These  observations 
constitute a unique example of heterogeneity of an integral membrane receptor. 
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